Quick Answer
Solid Biosciences Inc. reported Stockholders Equity of $180.01 million for fiscal year 2025.
Solid Biosciences Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $180.01M | +31.2% |
| 2024 | $137.25M | +8.5% |
| 2023 | $126.48M | -40.2% |
| 2022 | $211.67M | +1.7% |
| 2021 | $208.21M | +57.6% |
| 2020 | $132.09M | +65.0% |
| 2019 | $80.05M | -36.1% |
| 2018 | $125.18M | +311.3% |
| 2017 | -$59.26M | -56.4% |
| 2016 | -$37.89M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $217.95M | +30.5% | -15.6% |
| June 30, 2025 | $258.29M | +33.7% | -12.3% |
| March 31, 2025 | $294.46M | +39.7% | +114.6% |
| December 31, 2024 | $137.25M | +8.5% | -17.8% |
| September 30, 2024 | $167.02M | +15.7% | -13.6% |
| June 30, 2024 | $193.25M | +18.0% | -8.3% |
| March 31, 2024 | $210.72M | +14.7% | +66.6% |
| December 31, 2023 | $126.48M | -40.2% | -12.4% |
- Solid Biosciences Inc. showed an increase of +31.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Solid Biosciences Inc.’s stockholders equity has grown by 575.1% (from -$37.89 million to $180.01 million).
- The most recent figure is from Solid Biosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: